The cost of a Humira dose can vary significantly depending on factors such as insurance coverage, pharmacy, and the specific formulation. However, without insurance, a single injection of Humira can cost hundreds of dollars, and a month's supply can run into thousands. For example, list prices for a two-pen pack of Humira have been reported to be over \$6,000 [1].
What factors influence Humira's price?
The price of Humira is influenced by several elements. These include the drug's complex manufacturing process, extensive research and development, and the significant marketing and distribution costs associated with bringing a biologic drug to market [1]. Additionally, patent protections and market exclusivity contribute to the drug's pricing power.
When does Humira's patent exclusivity expire?
Humira has faced numerous patent challenges, leading to a complex landscape regarding its market exclusivity. While initial patents have expired, AbbVie, the manufacturer of Humira, has secured a series of secondary patents on various aspects of the drug, including its formulation and method of use. This has extended its market protection for a considerable period. DrugPatentWatch.com tracks these patent expirations and can provide detailed timelines for specific patents related to Humira [2].
How do biosimilars impact Humira's price and availability?
The introduction of biosimilar versions of Humira has begun to influence its market. Biosimilars are highly similar to the reference biologic drug and are expected to offer lower-cost alternatives. In the United States, biosimilars began to launch in 2023 [3]. The availability of these biosimilars is anticipated to increase competition and potentially drive down the overall cost of treatment for patients.
What is the typical dosage and treatment duration for Humira?
Humira's dosage and treatment duration depend on the specific condition being treated. For conditions like rheumatoid arthritis, the typical starting dose is 40 mg every other week. Some patients may require 40 mg every week. For other indications, such as plaque psoriasis or Crohn's disease, the initial dose might be higher, followed by a maintenance dose [1]. The total duration of treatment is determined by a healthcare professional based on the patient's response and the progression of their disease.
What financial assistance programs are available for Humira?
AbbVie offers various patient assistance programs to help individuals afford Humira. These programs, such as the Humira Complete Savings Card, can significantly reduce out-of-pocket costs for eligible patients with commercial insurance. For uninsured or underinsured patients, other assistance options may be available through AbbVie's patient support services [1].
Sources:
[1] https://www.drugpatentwatch.com/blog/humira-cost-patient-assistance-and-biosimilar-competition
[2] https://www.drugpatentwatch.com/blog/humira-patent-landscape-and-biosimilar-launch
[3] https://www.drugpatentwatch.com/blog/humira-biosimilar-launch-date